Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Chikungunya Infection in Neonates
NCT02230163Phase 2Unknown
- Sponsor
- Pointe-à-Pitre University Hospital
- Start
- Sep 2014
- Primary completion
- Oct 2015
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of anti-CHIKV hyperimmune immunoglobulins in Chikungunya (CHIKV), sponsored by Pointe-à-Pitre University Hospital. Status: unknown.
02
Drugs
anti-CHIKV hyperimmune immunoglobulins
03
Conditions
Chikungunya (CHIKV)
Beyond the preview
Go deeper on NCT02230163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02230163.